Page 273 - Drug Class Review
P. 273
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Gauthier 82 Year: 2001 Canadian Institute for Health Research Study design: Retrospective data review of published RCTs Number of patients: NR To determine the incidence rates of adverse events for DON, GAL, and RIV 9 RCTs NR RCTs NR Page 167 of 205
Final Report Update 1 Adverse Events STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN REVIEW TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
